Month: March 2023

Mar 22 2023

Uncategorized

Defense: Tree of Life suspect has schizophrenia, epilepsy

by Clinical Editor

No Comments

The man accused of killing 11 people at the Tree of Life synagogue in 2018 has schizophrenia and epilepsy, his defense attorneys said in a court filing late Monday. The...

Mar 22 2023

Uncategorized

Karuna extends selloff while Wall Street backs schizophrenia candidate

by Clinical Editor

No Comments

Karuna Therapeutics (KRTX) dropped for the second straight session Tuesday, while analysts brushed off safety concerns linked to its schizophrenia candidate KarXT, Read the full story here.

Mar 21 2023

Uncategorized

Hype builds for Karuna’s schizophrenia drug with phase 3 data – FierceBiotech

by Clinical Editor

No Comments

Hype builds for Karuna’s schizophrenia drug with phase 3 data  FierceBiotech

Mar 21 2023

Uncategorized

Karuna’s schizophrenia drug meets goal, safety doubts drag shares – Reuters

by Clinical Editor

No Comments

Karuna’s schizophrenia drug meets goal, safety doubts drag shares  Reuters

Mar 21 2023

Uncategorized

Karuna Stock Jumps on Third Positive Trial for Schizophrenia Drug – Barron’s

by Clinical Editor

No Comments

Karuna Stock Jumps on Third Positive Trial for Schizophrenia Drug  Barron’s

Mar 21 2023

Uncategorized

Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia – Business Wire

by Clinical Editor

No Comments

Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia  Business Wire

Mar 21 2023

Uncategorized

Karuna therapy reduced psychosis reported by patients in key trial – STAT

by Clinical Editor

No Comments

Karuna therapy reduced psychosis reported by patients in key trial  STAT

Mar 21 2023

Uncategorized

Karuna’s schizophrenia drug meets goal, safety doubts drag shares

by Clinical Editor

No Comments

Karuna Therapeutics said its lead experimental drug significantly reduced schizophrenia symptoms in a late-stage trial, but concerns of it causing hypertension dragged the shares of the drug developer …

Mar 21 2023

Uncategorized

Karuna’s treatment for schizophrenia achieves study goals, bolsters FDA filing plans

by Clinical Editor

No Comments

Karuna Therapeutics said its treatment for schizophrenia reduced psychosis reported by patients — achieving the main goal of a large clinical trial.

Mar 21 2023

Uncategorized

Researchers work to identify new diagnostic tools for schizophrenia

by Clinical Editor

No Comments

The researchers wanted to understand why people who experience schizophrenia report feelings that their senses are being flooded by external stimuli despite the fact that the data, when monitoring the...